The appointment of Dr. Ingrid Skop, an anti-abortion Ob/Gyn, to the Texas maternal mortality and morbidity review committee has raised eyebrows due to the nature of her activism. The fact that she was chosen over another applicant for a position originally intended for a rural community member is concerning, especially since the committee was meant to include community members with lived experience advocating for patient care. The decision to appoint Dr. Skop despite the controversy surrounding her involvement in a Supreme Court case against mifepristone raises questions about the integrity and inclusivity of the committee.
The report highlighting the fact that medical devices often remain in use after a “recall” sheds light on a concerning lack of accountability within the FDA and the healthcare industry as a whole. The fact that even in Class I recalls, where devices have flaws that can cause serious injury or death, companies are allowed to simply “correct” the problem by retraining doctors or repairing the device is alarming. Patients are left at risk due to the FDA’s leniency towards device manufacturers, as evidenced by the cases of Abbott’s MitraClip line and Medtronic’s StealthStation S7 cranial software, which have both had multiple recalls but remain in use.
The investigation into UnitedHealth’s use of the QuantaFlo device for screening peripheral artery disease (PAD) reveals a profit-driven approach that has raised concerns among doctors and experts. The widespread use of QuantaFlo, despite its lack of accuracy and potential for false positives, allowed UnitedHealth to earn billions in reimbursement from Medicare Advantage. The fact that the device was quickly incorporated into primary care clinics and home visit programs without proper validation of its effectiveness raises ethical questions about the company’s priorities.
The articles featured in this edition of Investigative Roundup highlight several concerning trends in the healthcare industry. From controversial appointments to medical device recalls and profit-driven practices, there are significant issues that need to be addressed to ensure the safety and well-being of patients. This critical analysis emphasizes the importance of holding healthcare providers and regulators accountable for their actions and decisions, and advocates for greater transparency and ethical standards in the field of healthcare.
Leave a Reply